Rare diseases
Investigational molecules
Locations
Study on the Effectiveness of Paclitaxel, Docetaxel, and Oxaliplatin in Patients with Resectable Gastric Cancer
The NetherlandsStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
AustriaStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
CzechiaStudy of ALX148 and Azacitidine for Untreated Higher Risk Myelodysplastic Syndrome Patients
SpainLong-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A
BelgiumStudy on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis
BelgiumScreening for Hidden Cancer Using FDG PET/CT and Gallium (68Ga) Chloride in Patients Aged 50+ with Unexplained Blood Clots
FranceStudy Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
BelgiumStudy of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma
CzechiaStudy of Nivolumab and Relatlimab for Patients with Resectable Non-Small Cell Lung Cancer
BelgiumStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
AustriaStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
